- Sections
- C - Chimiemétallurgie
- C08L - Compositions contenant des composés macromoléculaires
- C08L 5/04 - Acide alginiqueSes dérivés
Détention brevets de la classe C08L 5/04
Brevets de cette classe: 462
Historique des publications depuis 10 ans
|
27
|
24
|
41
|
46
|
36
|
52
|
42
|
46
|
59
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Board of Regents, The University of Texas System | 5725 |
13 |
| Case Western Reserve University | 1787 |
10 |
| Sigilon Therapeutics, Inc. | 100 |
8 |
| President and Fellows of Harvard College | 5926 |
7 |
| Northwestern University | 3337 |
7 |
| Mochida Pharmaceutical Co., Ltd. | 341 |
6 |
| Nisshinbo Holdings Inc. | 362 |
5 |
| The Regents of the University of California | 19752 |
4 |
| The General Hospital Corporation | 4687 |
4 |
| Allergan Pharmaceuticals International Limited | 219 |
4 |
| Drexel University | 983 |
4 |
| Norwegian University of Science and Technology (ntnu) | 179 |
4 |
| Nordovo Biosciences AS | 6 |
4 |
| HCS Innovation LLC | 6 |
4 |
| Centre National de La Recherche Scientifique | 10253 |
3 |
| Massachusetts Institute of Technology | 9967 |
3 |
| Academisch Ziekenhuis Maastricht | 180 |
3 |
| Cresilon, Inc. | 25 |
3 |
| Decision Sciences Medical Company, LLC | 35 |
3 |
| Kemira Oyj | 1184 |
3 |
| Autres propriétaires | 360 |